These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

849 related articles for article (PubMed ID: 21897887)

  • 1. Intention-to-treat concept: A review.
    Gupta SK
    Perspect Clin Res; 2011 Jul; 2(3):109-12. PubMed ID: 21897887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intention-to-treat analysis may be more conservative than per protocol analysis in antibiotic non-inferiority trials: a systematic review.
    Bai AD; Komorowski AS; Lo CKL; Tandon P; Li XX; Mokashi V; Cvetkovic A; Findlater A; Liang L; Tomlinson G; Loeb M; Mertz D;
    BMC Med Res Methodol; 2021 Apr; 21(1):75. PubMed ID: 33874894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The intention-to-treat approach in randomized controlled trials: are authors saying what they do and doing what they say?
    Gravel J; Opatrny L; Shapiro S
    Clin Trials; 2007; 4(4):350-6. PubMed ID: 17848496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intention-to-treat analysis in the chronic suppurative otitis media trials.
    Otwombe KN; Ogutu B
    East Afr Med J; 2003 Jun; 80(6):308-11. PubMed ID: 12953740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of the intention-to-treat principle in nursing clinical trials.
    Polit DF; Gillespie BM
    Nurs Res; 2009; 58(6):391-9. PubMed ID: 19918150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review found that deviations from intention-to-treat are common in randomized trials and systematic reviews.
    Abraha I; Cozzolino F; Orso M; Marchesi M; Germani A; Lombardo G; Eusebi P; De Florio R; Luchetta ML; Iorio A; Montedori A
    J Clin Epidemiol; 2017 Apr; 84():37-46. PubMed ID: 28088592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analyzing phase III studies in hospice/palliative care. a solution that sits between intention-to-treat and per protocol analyses: the palliative-modified ITT analysis.
    Currow DC; Plummer JL; Kutner JS; Samsa GP; Abernethy AP
    J Pain Symptom Manage; 2012 Oct; 44(4):595-603. PubMed ID: 22819439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intention-to-treat and transparency of related practices in randomized, controlled trials of anti-infectives.
    Beckett RD; Loeser KC; Bowman KR; Towne TG
    BMC Med Res Methodol; 2016 Aug; 16(1):106. PubMed ID: 27557676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in efficacy between intention-to-treat and per-protocol analyses for patients with psoriasis vulgaris and atopic dermatitis: clinical and pharmacoeconomic implications.
    Schiffner R; Schiffner-Rohe J; Gerstenhauer M; Hofstädter F; Landthaler M; Stolz W
    Br J Dermatol; 2001 Jun; 144(6):1154-60. PubMed ID: 11422035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating effects from randomized trials with discontinuations: the need for intent-to-treat design and G-estimation.
    Greenland S; Lanes S; Jara M
    Clin Trials; 2008; 5(1):5-13. PubMed ID: 18283074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deviation from intention to treat analysis in randomised trials and treatment effect estimates: meta-epidemiological study.
    Abraha I; Cherubini A; Cozzolino F; De Florio R; Luchetta ML; Rimland JM; Folletti I; Marchesi M; Germani A; Orso M; Eusebi P; Montedori A
    BMJ; 2015 May; 350():h2445. PubMed ID: 26016488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified versus standard intention-to-treat reporting: are there differences in methodological quality, sponsorship, and findings in randomized trials? A cross-sectional study.
    Montedori A; Bonacini MI; Casazza G; Luchetta ML; Duca P; Cozzolino F; Abraha I
    Trials; 2011 Feb; 12():58. PubMed ID: 21356072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intent-to-Treat (ITT) vs Completer or Per-Protocol Analysis in Randomized Controlled Trials.
    Andrade C
    Indian J Psychol Med; 2022 Jul; 44(4):416-418. PubMed ID: 35949630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
    Nanni O; Viale P; Vertogen B; Lilli C; Zingaretti C; Donati C; Masini C; Monti M; Serra P; Vespignani R; Grossi V; Biggeri A; Scarpi E; Galardi F; Bertoni L; Colamartini A; Falcini F; Altini M; Massa I; Gaggeri R; Martinelli G
    Trials; 2020 Jul; 21(1):689. PubMed ID: 32736597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial.
    Brown JE; Royle KL; Gregory W; Ralph C; Maraveyas A; Din O; Eisen T; Nathan P; Powles T; Griffiths R; Jones R; Vasudev N; Wheater M; Hamid A; Waddell T; McMenemin R; Patel P; Larkin J; Faust G; Martin A; Swain J; Bestall J; McCabe C; Meads D; Goh V; Min Wah T; Brown J; Hewison J; Selby P; Collinson F;
    Lancet Oncol; 2023 Mar; 24(3):213-227. PubMed ID: 36796394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intention-to-treat analysis: who is in? Who is out?
    Kruse RL; Alper BS; Reust C; Stevermer JJ; Shannon S; Williams RH
    J Fam Pract; 2002 Nov; 51(11):969-71. PubMed ID: 12485553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intention to treat (ITT) analysis as reported in orthodontic randomized controlled trials-evaluations of methodology and recommendations for the accurate use of ITT analysis and handling dropouts.
    Bondemark L; Abdulraheem S
    Eur J Orthod; 2018 Jul; 40(4):409-413. PubMed ID: 29069355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addressing missing participant outcome data in dental clinical trials.
    Spineli LM; Fleming PS; Pandis N
    J Dent; 2015 Jun; 43(6):605-18. PubMed ID: 25837533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.